Towards Healthcare
Digital Pathology Market USD 2.51 Bn at 8.24% CAGR by 2034

Digital Pathology Market Size, Trends, Dynamics and Consumer Preferences & Behavior

According to forecasts, the global digital pathology market will grow from USD 1.14 billion in 2024 to USD 2.51 billion by 2034, with an expected CAGR of 8.24%. The development of extensive chronic diseases like cancer, primarily, by which the digital pathology market is getting influenced, as it increases the rate of diagnosis, raises the diagnostic accuracy, and offers therapeutic guidance to enhance patient outcomes. North America dominated the market in 2024, due to the enhanced development of the advanced healthcare infrastructure.

Category: Diagnostics Insight Code: 5647 Format: PDF / PPT / Excel

Digital Pathology Market Innovation, Investment and Competitive Strategies

The global digital pathology market size is calculated at USD 1.14 in 2024, grew to USD 1.23 billion in 2025, and is projected to reach around USD 2.51 billion by 2034. The market is expanding at a CAGR of 8.24% between 2025 and 2034.

Digital Pathology Market Size 2024 - 2034

Key Takeaways

  • Digital pathology industry poised to reach USD 1.14 billion in 2024.
  • Forecasted to grow to USD 2.51 billion by 2034.
  • Expected to maintain a CAGR of 8.24% from 2025 to 2034.
  • North America led the digital pathology market share 41% in 2024.
  • Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period.
  • By product type, the device segment held the largest share in 2024.
  • By product type, the software segment is predicted to grow at the fastest rate in the upcoming years.
  • By type, the human pathology segment held the largest share in 2024.
  • By type, the veterinary digital pathology segment is expected to grow significantly during the forecast period.
  • By application, the academic research segment led the digital pathology market in 2024.
  • By application, the disease diagnosis segment is predicted to grow at the fastest rate in the upcoming years.
  • By end use, the hospital segment held the largest market share in 2024.
  • By end use, the diagnostic labs segment is seen to grow at the fastest rate during the forecast period.

Key Metrics and Overview

Metric Details
Market Size in 2025 USD 1.23 Billion
Projected Market Size in 2034 USD 2.51 Billion
CAGR (2025 - 2034) 8.24%
Leading Region North America share by 41%
Market Segmentation By Product type, By Type, By Application type, By End Use type, By Region
Top Key Players F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, 3DHISTECH Ltd., PathAI, Paige, Proscia, Danaher Corporation, Hamamatsu Photonics K.K.

Market Overview

Digital pathology is described by, involves altering physical glass slides of tissue samples into high-resolution images for observing and examining on the computer monitor. Different computer-aided diagnostic (CAD) tools can be used in digital pathology, along with artificial intelligence (AI) and machine learning (ML), to encourage recognition and quantification of pathological characteristics. The market has been showing rising demand for these tools as there is an increasing prevalence of chronic diseases like cancer, and also enhancing the focus on optimizing workflow efficiency.

The Number of Hospitals in 2024 in Different Countries-01

  • In January 2025, NVIDIA announced partnerships with Industry Leaders to Advance Genomics, Drug Discovery, and Healthcare. These partnerships will enhance drug discovery and development, raise genomic research, and introduce advanced healthcare services with agentic and generative AI. (Source - nvidia)
  • In January 2025, Leica Biosystems, a provider of anatomic and digital pathology solutions, announced an alliance with Indica Labs, which is a company concentrating on AI-powered digital pathology software. The goal of this alliance is to develop advanced AI-aided companion diagnostics (CDx) and to assist in biomarker analysis of cancer and other diseases. (R & D World)

How is AI Impacting the Digital Pathology Market?

AI has the potential to increase the accuracy, efficiency, and completeness of the workflow of pathology, which results in improved patient care and certainly decreased costs. One of the developed technologies, called telepathology, AI-aided, permits pathologists to review slides from home, approach expert consultations, and deliver the diagnosis to patients from different geographical locations. By increased use of AI-based tools in medical care and an increase in capital investments, progress is contributing to a rise in demand for the technology in the digital pathology market.

Market Dynamics

Driver

Enhanced Investments and Utilization of Technology

As a rising chronic instances and cancer, which require rapid and highly accurate diagnostic approaches, are impelling the digital pathology as a significant tool. Moreover, nowadays, increasing investments in healthcare along with main leaders who regulate the focus on new launches in the market, rising utilization of telepathology, and raised aim on drug discovery, are influencing the market growth.

Restraint

Barriers to Integration and Data Security

Integration of digital pathology with functional laboratory operations, electronic health records (EHRs), and laboratory information systems (LISs) can lead to complications. For this, modifications in processes, personnel training, and ensuring harmony with the working infrastructure are required. Besides this, digital pathology possesses sensitive patient information, which has raised increasing concerns about data security and privacy.

Opportunity

Raise Business Opportunities with AI-Aided Applications.

The digital pathology market is showing significant growth as it is impelled by advancements in AI, enhanced telepathology applications, and increasing healthcare expenses. Various business opportunities are generating like digital pathology solutions, hardware production, software development, and service providers. As the AI increases the accuracy and decreases the completion time for pathology reports, it can also make the tasks automated, such as slide scanning and sorting, liberating pathologists for more complicated analysis.

Segmental Insights

The Device Segment Held the Largest Share

By product type, the device segment held the largest share of the digital pathology market in 2024. Slide management systems and scanners are involved in the device segment. In academic research activities, this segment has shown growth with raised resolution power. These slides can be used in the digitization of tissue analysis, as they are generating high-resolution tissue samples’ digital images, resulting in convenient reviewing and analyzing the reports at remote locations and more efficiently.

The Software Segment: Fastest Growing

By product type, the software segment is predicted to grow at the fastest rate in the upcoming years. This segment is experiencing significant growth, as AI and ML are employed, which are assisting in pathology report analysis and raising the diagnostic accuracy level, as well as making the workflows more efficient. Some eminent examples include ImageJ/Fiji, QuPath, CellProfiler, Cytomine, and commercial platforms like Aperio and Proscia's Concentriq LS. 

The Human Pathology Segment Held the Major Share

By type, the human pathology segment held the largest share of the digital pathology market in 2024. Rise in demand for accuracy and systematic diagnosis, specifically in chronic diseases such as cancer, is driving the human pathology segment for market growth. However, the integration of digital pathology with AI and ML is contributing to the rapid pace, accuracy, and effectiveness of pathological analysis, which results in enhanced patient outcomes.

The Veterinary Digital Pathology Segment: Significantly Growing

By type, the veterinary digital pathology segment is expected to grow significantly during the forecast period. The increasing number of animal associations and enhanced awareness about animal health are contributing to the demand for digital pathology in veterinary. With minimum restrictions in veterinary diagnoses using virtual scanned slides are promoting the implementation of digital pathology in the veterinary sector.

The Academic Research Segment Dominated the Market

By application, the academic research segment led the market in 2024. Numerous academic research institutes are aligning with digital pathology providers to include the technology in research activities. For the conversion of glass slides into digital images for analysis, which assists the research in several domains like tumor morphology and disease response, digital pathology is widely applied. Applications with advanced technologies, AI-aided image analysis influencing the growth of the digital pathology market.

The Disease Diagnosis Segment: Fastest Growing Rate

By application, the disease diagnosis segment is predicted to grow at the fastest rate in the upcoming years. The growth of this segment is greatly influenced by, rising prevalence of chronic diseases, and the rising target for the development of faster and new diagnostic techniques for the timely exchange of inter- and intra-departmental information by manufacturers. By the application of advanced technologies, it supports upgrading and increasing the efficiency of disease diagnosis and, thus, improves the therapeutics.

The Hospital Segment Held The Major Share

By end use, the hospital segment held the largest digital pathology market share in 2024. Hospitals with having higher number of patients are resulting in rising demand for more accurate and efficient pathology services. The growth of the market is propelled by enhanced diagnostic pace, which provides rapid patient care from hospitals by using digital pathology systems. Also, it gives simplified workflows, leads to enhanced productivity, and decreased processing time.

The Diagnostic Labs Segment: Fastest Growing

By end use, the diagnostic labs segment is seen to grow at the fastest rate during the forecast period. Globally, rising cancer instances and enhanced clinical trials of oncology are driving for growth of digital pathology in diagnostic labs. Technological advancements like whole-slide imaging and AI integration are playing a major role in the growth of this segment.

Regional Insights

Digital Pathology Market Share, By Region, 2024 (%)

How Did North America Dominate the Market in 2024?

North America led the digital pathology market share by 41% in 2024. Primarily, the growth is impacted by the rise in cancer cases, advanced healthcare infrastructures, and technological advancements. As a government encouraging technological development for advanced pathologies, frequent R&D investments, enhanced digital imaging approaches, and the participation of market leaders of the region, aiming to provide exceptional solutions to the population.

The U.S. Digital Pathology Market Trends

Enhanced approaches of digital pathology are influenced by factors such as technological advancements, regulatory modifications, and the possible increased efficiency and inexpensive. Although, as a developing, less than 10% of US organizations are encouraging digital pathology for clinical purposes, which has been predicted to rise in the forecast period.

The Canada Digital Pathology Market Trends

Canada is a vital core for the advancement and acquisition of digital pathology, fueled by the demand to overcome the geographical hurdles of providing various expert services across the country. Canada has an uncommon situation, such as scattered population centers and trouble in transportation of specimens and specialists, which forces digital pathology as a crucial tool in providing services with high-quality services.

Raised Acquisition of Digital Technologies Is Driving Asia Pacific

Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period, which is propelled by the rising acquisition of digital technologies, rising awareness of its advantages, and demand for enhanced diagnostic effectiveness and accuracy. Along with this, integrated AI and ML are allied with the progress of inexpensive solutions, which may lead to the expansion of the market in the upcoming period.

The China Digital Pathology Market Trends

In China, boosting the patient population, unsatisfied medical necessities, and government initiatives are accelerating technological advancements. The market trend in China comprises teleconsultation, disease diagnosis, training and education, and most importantly, AI-based image analysis for increased accuracy and efficiency.

The Japan Digital Pathology Market Trends

In Japan, the market is facing significant growth as it is fueled by factors such as a rising geriatric population and limitations of pathologists. Also, it has been employed in education, remote consultation, disease diagnosis, and research in the country. AI and ML-based technology are playing a vital role in the growth of the market.

Rising Concerns About Chronic Diseases are Driving the Europe

The market of Europe is showing significant growth, which is fueled by the rise in prevalence of chronic diseases like cancer, cardiovascular conditions, and diabetes, as well as a larger number of emerging diagnostic imaging centers. This rising concerns demand highly precise and appropriate diagnostic tools; besides this, arising government investments in R&D in digital pathology are a major factor that assists in the growth of the market.

The UK Digital Pathology Market Trends

The UK market is experiencing rapid market growth, as it is impelled by enhanced needs for remote diagnostics, AI-based tools, and the necessity for a highly efficient digital pathology market. To maximize the specialized services and lessen the processing time, remote reviewing and consultation with a pathologist by using digital pathology slides are becoming widely employed in the market growth. Whereas, application of AI integration algorithms into digital pathology systems permits for automated analysis, predictive analytics, and more effective diagnoses.

The Germany Digital Pathology Market Trends

In Germany, the market is facing significant growth, which is influenced by factors like increased acquisitions of technological advancements and advantages of remote alliance with AI-aided tools. Telepathology is playing a crucial role in the growth of the market, as it is feasible to review the slides and consultation from any location or remotely. Furthermore, digital pathology is more convenient than conventional methods and is cost-effective as well.

Top Companies in the Digital Pathology Market

Digital Pathology Market Companies

Latest Announcements by Industry Leaders

  • In April 2025, Honeywell presented TrackWise Manufacturing, which is an artificial intelligence (AI)-aided, cloud native platform created for modification in life science companies to determine how they manage, automate, and digitalize processes. Pramesh Maheshwari, president of Honeywell Process Solutions, replied that, to achieve advances in industry’s saved systems by imposing Honeywell’s substantial expertise in automation technologies, and life science compliance, TrackWise Manufacturing has been created. (Source - European Pharmaceutical Manufacturer)
  • In September 2024, the leader in AI-powered pathological solutions, Mindpeak, announced about $15.3 million in funding in a Series A funding round, which was dominated by ZEISS Ventures and InnoVentureFund, along the contributions from other AI.FUND and the European Innovation Council Fund. Felix Faber, CEO of Mindpeak, said that this new funding will accelerate the development and implementation of AI solutions, authorizing pathologists and researchers with rapid, more efficient diagnostic tools. (Source - businesswire)

What are the Recent Developments in the Digital Pathology Market?

  • In January 2025, Mayo Clinic launched Mayo Clinic digital pathology to update pathology, accelerate the pace of medical developments. (Source - MAYO CLINIC)
  • In February 2025, Optiscan Imaging introduced a future generation medical imaging microscope, dubbed InForm, created to accelerate and optimize the pathology testing by applying actual, in-the-present digital imaging of tissue samples. (Source - SMH)

Segments Covered in the Report

By Product type

  • Software
  • Traditional
  • AI-enabled
  • Device
  • Scanners
  • Traditional
  • AI-Enabled
  • Slide Management Systems
  • Traditional
  • AI-Enabled
  • Storage System
  • Traditional
  • AI-Enabled

By Type

  • Human Pathology
  • Veterinary Pathology

By Application type

  • Drug Discovery & Development
  • Academic Research
  • Disease Diagnosis
  • Cancer Cell Detection
  • Others

By End Use type

  • Hospitals
  • Biotech & Pharma Companies
  • Diagnostic Labs
  • Academic & Research Institutes

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
  • Last Updated: 27 May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations.

Learn more about Kesiya Chacko

Aditi Shivarkar, with over 14 years of experience in consumer goods, leads research at Towards Consumer Goods, ensuring precise, actionable insights on trends, consumer preferences, and sustainable packaging for businesses.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

Primarily, clinical pathologists, lab directors, researchers, professors, also pathologists are in high demand in diagnostic labs and hospitals.

The techniques of high-resolution analysis in histology which is a major benefit of AI-aided tools.

Widely utilized by biopharmaceuticals and top clinical research organizations (CROs) to simplify the drug discovery and development processes, pre-clinical and clinical trials.

NIH.GOV, FDA.GOV, NCI.GOV, GOV.UK